Prefer a chat interface with context about you and your work?
A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables
Early biomarkers are helpful for predicting clinical endpoints and for evaluating efficacy in clinical trials even if the biomarker cannot replace clinical outcome as a surrogate. The building and evaluation of an association model between biomarkers and clinical outcomes are two equally important concerns regarding the prediction of clinical outcome. …